The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Patients with eosinophilic esophagitis face significant economic burdens, according to a pair of presentations at Digestive ...

Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...

Children and young adults in states with high Medicaid disenrollment rates were more likely to experience disruptions in ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for ...

Long-term outcomes after CT or invasive coronary angiography to diagnose CAD were similar, with comparable improvement in ...

Drug and alcohol references in popular music not only correlate with use, but they also provide opportunities for engaging ...

Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

A hand hygiene intervention, which encouraged patients and visitors to the participating units to perform audits of health ...